Xenon Pharmaceuticals (XENE) PT Raised to $45 at Guggenheim, Following Clinical Business Update
Guggenheim analyst Yatin Suneja raised ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
